Cancer Drug Resistance
All Journals
Search Log In
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase,
Journal Rank: CiteScore 5.5 - Q2 (Pharmacology(medical))   Submission to first decision: 63 days
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Editor-in-Chief: Godefridus J. Peters
Journal Rank: CiteScore 5.5 - Q2 (Pharmacology(medical))
Submission to first decision: 63 days
Home Articles Special Issues Volumes Webinars Videos

Cancer Drug Resistance

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Articles

Most Recent | Most Viewed | Most Downloaded

The therapeutic potential of circular RNA in triple-negative breast cancer

Aiqi Xu, ... Ziyun Guan
Open Access Review DOI: 10.20517/cdr.2023.141 22 Apr 2024
Views: Downloads:
Download PDF

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

Leonie De Wilt, ... Frank Kruyt
Open Access Original Article DOI: 10.20517/cdr.2024.14 8 Apr 2024
Views: Downloads:
Download PDF

Dysregulation of calcium homeostasis in cancer and its role in chemoresistance

Neema KumariNeema Kumari, ... Kranti Kiran Reddy EallaKranti Kiran Reddy Ealla
Open Access Review DOI: 10.20517/cdr.2023.145 14 Mar 2024
Views: Downloads:
Download PDF

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

Guillaume Sicard, ... Raphaelle Fanciullino
Open Access Original Article DOI: 10.20517/cdr.2023.146 13 Mar 2024
Views: Downloads:
Download PDF

Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer

Dong-Liang ChenDong-Liang Chen, ... Dong-Sheng Zhang
Open Access Original Article DOI: 10.20517/cdr.2023.151 12 Mar 2024
Views: Downloads:
Download PDF

Venetoclax resistance: mechanistic insights and future strategies

Faustine Ong, ... Marina Y. Konopleva
Open Access Review DOI: 10.20517/cdr.2021.125 5 May 2022
Views: Downloads:
Download PDF

Improving HER2 testing reproducibility in HER2-low breast cancer

Elham Sajjadi, ... Nicola FuscoNicola Fusco
Open Access Opinion DOI: 10.20517/cdr.2022.29 31 Aug 2022
Views: Downloads:
Download PDF

Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces

Ahmad R. Safa
Open Access Review DOI: 10.20517/cdr.2022.20 1 Aug 2022
Views: Downloads:
Download PDF

Topic: Innovative Strategies for Overcoming Multidrug Resistance in Breast Cancer

Prof. Kenneth Kin Wah To; Dr. Suresh V. Ambudkar

Submission Deadline: 28 Feb 2025

Published articles: 0

Topic: Pioneering Strategies to Combat Drug Resistance in Prostate Cancer

Dr. Pallabita Chowdhury;  Dr. Murali M. Yallapu

Submission Deadline: 15 Jan 2025

Published articles: 0

Data
1535
Authors
1021
Reviewers
383
Articles
107
On Board Editors
2018
Published Since
57
Special Issues
1,358,069
Article Views
400,386
Article Downloads
For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Topic: Research on Drug Resistance of Chronic Lymphoid Leukemia
Topic: DNA Repair & Metabolism and Cancer Drug Resistance
Topic: Resistance to Cancer Immunotherapy: Mechanisms, Advances, Challenges and Opportunities
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Articles Collection
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

The Special Collection "Cancer Cell Plasticity in Therapy Resistance" Officially Launched and Open for Submissions
Four Editorial Board Members Promoted to Associate Editors at the Journal of Cancer Drug Resistance
Their promotion recognizes their exceptional contributions to the journal and their steadfast dedication to advancing research in the field of cancer drug resistance.
Professor Yehuda G Assaraf Promoted to Co-Editor-in-Chief of Cancer Drug Resistance Journal
We are delighted to announce the promotion of Prof. Yehuda G Assaraf to the position of Co-Editor-in-Chief of CDR juornal
Cancer Drug Resistance Journal Initiates Global Recruitment for Junior Editorial Board Members
Join CDR Journal's Junior Editorial Board for a Pioneering Academic Experience
Cancer Drug Resistance 2023 Annual Progress Report – Remarkable Highlights
Showcasing a year of remarkable strides and achievements
Reviewers Acknowledgement for 2023
In the intricate tapestry of academic publishing, reviewers serve as the unsung heroes, diligently ensuring the rigor, clarity, and integrity of scholarly work.

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Venetoclax resistance: mechanistic insights and future strategies
Faustine Ong, ... Marina Y. Konopleva
Open Access | Review | 5 May 2022
Views: | Downloads:
Download PDF
Improving HER2 testing reproducibility in HER2-low breast cancer
Elham Sajjadi, ... Nicola FuscoNicola Fusco
Open Access | Opinion | 31 Aug 2022
Views: | Downloads:
Download PDF
Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces
Ahmad R. Safa
Open Access | Review | 1 Aug 2022
Views: | Downloads:
Download PDF

Topic: Innovative Strategies for Overcoming Multidrug Resistance in Breast Cancer

Prof. Kenneth Kin Wah To; Dr. Suresh V. Ambudkar

Submission Deadline: 28 Feb 2025

Published articles: 0

Topic: Pioneering Strategies to Combat Drug Resistance in Prostate Cancer

Dr. Pallabita Chowdhury;  Dr. Murali M. Yallapu

Submission Deadline: 15 Jan 2025

Published articles: 0

Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

Data
1535
Authors
1021
Reviewers
383
Articles
107
On Board Editors
2018
Published Since
57
Special Issues
1,358,069
Article Views
400,386
Article Downloads
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties